FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Adjuvant therapy with a modified FOLFIRINOX regimen led to significantly longer survival than gemcitabine among patients with resected pancreatic cancer, at the expense of a hig...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 2,673
- Institution
- Centre Hospitalier Universitaire de Tours
External Links
Identifiers
- ORCID
- 0000-0001-5093-0212
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.